Clinical Trial Update: Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zoledronate with or without thalidomide in early-stage multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thalidomide (thalidomide)
• Zoledronate (zoledronic acid)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: COMPLETED | Results posted: 2012-07-04